The signaling and functions of heterodimeric bone morphogenetic proteins.

[1]  G van der Pluijm,et al.  The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation , 2012, Oncogene.

[2]  Z. Gu,et al.  BMP2/7 heterodimer can modulate all cellular events of the in vitro RANKL-mediated osteoclastogenesis, respectively, in different dose patterns. , 2012, Tissue engineering. Part A.

[3]  Y. Henis,et al.  Homomeric and heteromeric complexes among TGF-β and BMP receptors and their roles in signaling. , 2011, Cellular signalling.

[4]  A. Nohe,et al.  Bone morphogenetic proteins: a critical review. , 2011, Cellular signalling.

[5]  Benjamin M Wu,et al.  High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. , 2011, Tissue engineering. Part A.

[6]  C. Hidaka,et al.  Osteoblastic differentiation of human and equine adult bone marrow‐derived mesenchymal stem cells when BMP‐2 or BMP‐7 homodimer genetic modification is compared to BMP‐2/7 heterodimer genetic modification in the presence and absence of dexamethasone , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  J. I. Izpisúa Belmonte,et al.  Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly. , 2010, Molecular endocrinology.

[8]  J. I. Izpisúa Belmonte,et al.  BMP-2/6 Heterodimer Is More Effective than BMP-2 or BMP-6 Homodimers as Inductor of Differentiation of Human Embryonic Stem Cells , 2010, PloS one.

[9]  A. Kallioniemi,et al.  Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? , 2010, Endocrine-related cancer.

[10]  D. Brazil,et al.  Extracellular BMP-antagonist regulation in development and disease: tied up in knots. , 2010, Trends in cell biology.

[11]  Kazuhide Matsunaga,et al.  Treatment of orbital floor fracture using a periosteum-polymer complex. , 2010, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[12]  Z. Gu,et al.  rhBMP2/7 heterodimer: an osteoblastogenesis inducer of not higher potency but lower effective concentration compared with rhBMP2 and rhBMP7 homodimers. , 2010, Tissue engineering. Part A.

[13]  P. Knaus,et al.  Recent advances in BMP receptor signaling. , 2009, Cytokine & growth factor reviews.

[14]  E. D. De Robertis,et al.  Integration of BMP and Wnt signaling via vertebrate Smad1/5/8 and Drosophila Mad. , 2009, Cytokine & growth factor reviews.

[15]  A. Reddi.  Bone morphogenetic proteins (BMPs): from morphogens to metabologens. , 2009, Cytokine & growth factor reviews.

[16]  Joachim Nickel,et al.  Receptor oligomerization and beyond: a case study in bone morphogenetic proteins , 2009, BMC Biology.

[17]  Shawn C. Little,et al.  BMP heterodimers assemble hetero-type I receptor complexes that pattern the DV axis , 2009, Nature Cell Biology.

[18]  Z. Zhao,et al.  Combinatorial Gene Therapy with BMP2/7 Enhances Cranial Bone Regeneration , 2008, Journal of dental research.

[19]  Noel Claffey,et al.  Surgical treatment of peri-implantitis. , 2008, Journal of clinical periodontology.

[20]  M. Alaoui-Ismaili,et al.  BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells* , 2008, Journal of Biological Chemistry.

[21]  Q. Pan,et al.  [Expression of BMP-2/7 heterodimers with potent ability to stimulate osteogenic differentiation in CHO cells]. , 2008, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[22]  R L Reis,et al.  Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts) , 2008, Journal of tissue engineering and regenerative medicine.

[23]  A. Kotzsch,et al.  Type I receptor binding of bone morphogenetic protein 6 is dependent on N‐glycosylation of the ligand , 2008, The FEBS journal.

[24]  J. I. Izpisúa Belmonte,et al.  BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors. , 2007, Biochemistry.

[25]  K. Shakesheff,et al.  Polymer carriers for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[26]  Antonios G Mikos,et al.  Review: mineralization of synthetic polymer scaffolds for bone tissue engineering. , 2007, Tissue engineering.

[27]  M. Bostrom,et al.  Synthetic bone scaffolds and fracture repair. , 2007, Injury.

[28]  R. Crystal,et al.  Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. , 2006, Bone.

[29]  David M. Umulis,et al.  Shaping BMP morphogen gradients in the Drosophila embryo and pupal wing , 2005, Development.

[30]  A. Hoffmann,et al.  Transforming Growth Factor-β-activated Kinase-1 (TAK1), a MAP3K, Interacts with Smad Proteins and Interferes with Osteogenesis in Murine Mesenchymal Progenitors*[boxs] , 2005, Journal of Biological Chemistry.

[31]  A. Reddi.  BMPs: from bone morphogenetic proteins to body morphogenetic proteins. , 2005, Cytokine & growth factor reviews.

[32]  Zhuoran Zhao,et al.  Combinatorial gene therapy for bone regeneration: Cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7 , 2005, Journal of cellular biochemistry.

[33]  R. Crystal,et al.  Combined Bone Morphogenetic Protein‐2 and −7 Gene Transfer Enhances Osteoblastic Differentiation and Spine Fusion in a Rodent Model , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  W. Sebald,et al.  Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction , 2004, Biological chemistry.

[35]  Wei Zhu,et al.  888. A BMP2/7 Fusion Gene Enhances Osteoblastic Differentiation in Mesenchymal Cells , 2004 .

[36]  J. Massagué.  Integration of Smad and MAPK pathways: a link and a linker revisited. , 2003, Genes & development.

[37]  J. Lemonnier,et al.  Activation of p38 Mitogen‐Activated Protein Kinase and c‐Jun‐NH2‐Terminal Kinase by BMP‐2 and Their Implication in the Stimulation of Osteoblastic Cell Differentiation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[39]  P. Knaus,et al.  Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways , 2003, Journal of Cell Science.

[40]  K. Takaoka,et al.  New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. , 2003, Biomaterials.

[41]  J. Dodd,et al.  A Role for BMP Heterodimers in Roof Plate-Mediated Repulsion of Commissural Axons , 2003, Neuron.

[42]  F. Otsuka,et al.  Effect of Intracellular Interactions on the Processing and Secretion of Bone Morphogenetic Protein-15 (BMP-15) and Growth and Differentiation Factor-9 , 2003, The Journal of Biological Chemistry.

[43]  T. Albert,et al.  Donor Site Morbidity After Anterior Iliac Crest Bone Harvest for Single-Level Anterior Cervical Discectomy and Fusion , 2003, Spine.

[44]  Markus Affolter,et al.  Structural basis of BMP signalling inhibition by the cystine knot protein Noggin , 2002, Nature.

[45]  S. Boden,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.

[46]  Masaki Noda,et al.  Negative Regulation of Bone Morphogenetic Protein/Smad Signaling by Cas-interacting Zinc Finger Protein in Osteoblasts* , 2002, The Journal of Biological Chemistry.

[47]  R. Heary,et al.  Persistent Iliac Crest Donor Site Pain: Independent Outcome Assessment , 2002, Neurosurgery.

[48]  Anja Nohe,et al.  The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[49]  M. Kumegawa,et al.  Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. , 2000, Bone.

[50]  T. Kirsch,et al.  BMP‐2 antagonists emerge from alterations in the low‐affinity binding epitope for receptor BMPR‐II , 2000, The EMBO journal.

[51]  G. Karsenty,et al.  The family of bone morphogenetic proteins. , 2000, Kidney international.

[52]  J. Wozney,et al.  Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. , 1999, Journal of biomedical materials research.

[53]  K. Miyazono.  Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. , 1999, Bone.

[54]  S Kumar,et al.  Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers. , 1999, Genetics.

[55]  P. Hoodless,et al.  Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2* , 1998, The Journal of Biological Chemistry.

[56]  Y. Sasai,et al.  Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4 , 1996, Cell.

[57]  A. Aono,et al.  Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. , 1995, Biochemical and biophysical research communications.

[58]  N. Ueno,et al.  Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. , 1995, Biochemical and biophysical research communications.

[59]  J. Graff,et al.  Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo , 1994, Cell.

[60]  H. Oppermann,et al.  Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. , 1990, The Journal of biological chemistry.

[61]  E. Drier,et al.  OP‐1 cDNA encodes an osteogenic protein in the TGF‐beta family. , 1990, The EMBO journal.

[62]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[63]  V. Rosen,et al.  Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  M. Abramson,et al.  Membranous vs Endochondral Bone Autografts , 1974 .

[65]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[66]  Z. Gu,et al.  Low-dose rhBMP2/7 heterodimer to reconstruct peri-implant bone defects: a micro-CT evaluation. , 2012, Journal of clinical periodontology.

[67]  Kohei Miyazono,et al.  Bone morphogenetic protein receptors and signal transduction. , 2010, Journal of biochemistry.

[68]  Sun Fen-yong.  Relationship Between the Bioactivity of BMP2/7 Heterodimers and Its Regulation of CIZ Expression , 2007 .

[69]  L. Parker,et al.  Regulation of BMP and activin signaling in Drosophila. , 2004, Progress in molecular and subcellular biology.

[70]  V. Rosen,et al.  Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. , 1996, Growth factors.

[71]  E. Wang,et al.  Bone morphogenetic proteins induce differentiation in astrocyte lineage cells. , 1994, Growth factors.